Hebei Changshan Biochemical Pharmaceutical Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300255
  • 1d-1.36%
  • 1w-6.03%
  • 1m-22.26%
  • 1y81.73%
ATH
  • ATH Price$18.90
  • ATH Date2015-06-02
  • % since ATH-46.39%
  • % to ATH86.53%
ATL
  • ATL Price$1.98
  • ATL Date2012-01-16
  • % from ATL411.85%
  • Last Low Price$3.9845
  • Last Low Date2019-01-03
  • % From Last Low154.24%
IPO
  • IPO Price$28.38
  • % Current ROI USD-64.31%
  • ATH Price$18.90
  • % ROI ATH 95,472.69%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300255"]

Key Data [addtoany]

Current price $10.13
Sector Healthcare
Industry Biotechnology
Today's High/Low $10.37/$10.09
Volume 18,633,229.00
Previous Close $10.27
52 Week High/Low $17.98/$4.3
Market Cap 9,310,088,192.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0005
$10.13
[addtoany]

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of heparin and related products in China. Its API products include heparin sodium injections, heparin calcium and lithium injections, heparinoid, LMW heparins, and sodium hyaluronate.
The company also provides dalteparin and enoxaparin sodium injections, and nadroparin calcium injections, as well as sildenafil citrate tablets.
It markets and sells its products to approximately 30 countries worldwide. Hebei Changshan Biochemical Pharmaceutical Co., Ltd. was founded in 2000 and is based in Shijiazhuang, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity